{"id":"https://openalex.org/W3213036992","doi":"https://doi.org/10.3389/fcvm.2021.789931","title":"Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol","display_name":"Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol","publication_year":2021,"publication_date":"2021-11-17","ids":{"openalex":"https://openalex.org/W3213036992","doi":"https://doi.org/10.3389/fcvm.2021.789931","mag":"3213036992","pmid":"https://pubmed.ncbi.nlm.nih.gov/34869702","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8635697"},"language":"en","primary_location":{"id":"doi:10.3389/fcvm.2021.789931","doi":"https://doi.org/10.3389/fcvm.2021.789931","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fcvm.2021.789931","pdf_url":"https://www.frontiersin.org/articles/10.3389/fcvm.2021.789931/pdf","source":{"id":"https://openalex.org/S2595413687","display_name":"Frontiers in Cardiovascular Medicine","issn_l":"2297-055X","issn":["2297-055X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","oarl","poland-40","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Cardiovascular Medicine","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fcvm.2021.789931/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027219295","display_name":"Chandni Bardolia","orcid":"https://orcid.org/0000-0002-4561-9670","observed_orcids":["https://orcid.org/0000-0002-4561-9670"]},"institutions":[{"id":"https://openalex.org/I4405271950","display_name":"Tabula Rasa HealthCare (United States)","ror":"https://ror.org/03akc2z91","country_code":"US","type":"company","lineage":["https://openalex.org/I4405271950"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Chandni Bardolia","raw_affiliation_strings":["Office of Translational Research and Residency Programs, Tabula Rasa HealthCare, Moorestown, NJ, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of Translational Research and Residency Programs, Tabula Rasa HealthCare, Moorestown, NJ, United States","institution_ids":["https://openalex.org/I4405271950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022521073","display_name":"Nishita Shah Amin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405271950","display_name":"Tabula Rasa HealthCare (United States)","ror":"https://ror.org/03akc2z91","country_code":"US","type":"company","lineage":["https://openalex.org/I4405271950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nishita Shah Amin","raw_affiliation_strings":["Office of Translational Research and Residency Programs, Tabula Rasa HealthCare, Moorestown, NJ, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of Translational Research and Residency Programs, Tabula Rasa HealthCare, Moorestown, NJ, United States","institution_ids":["https://openalex.org/I4405271950"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080359453","display_name":"Jacques Turgeon","orcid":"https://orcid.org/0000-0002-7978-9280","observed_orcids":["https://orcid.org/0000-0002-7978-9280"]},"institutions":[{"id":"https://openalex.org/I4405271950","display_name":"Tabula Rasa HealthCare (United States)","ror":"https://ror.org/03akc2z91","country_code":"US","type":"company","lineage":["https://openalex.org/I4405271950"]},{"id":"https://openalex.org/I70931966","display_name":"Universit\u00e9 de Montr\u00e9al","ror":"https://ror.org/0161xgx34","country_code":"CA","type":"education","lineage":["https://openalex.org/I70931966"]}],"countries":["CA","US"],"is_corresponding":false,"raw_author_name":"Jacques Turgeon","raw_affiliation_strings":["Faculty of Pharmacy, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC, Canada","Precision Pharmacotherapy Research and Development Institute, Tabula Rasa HealthCare, Lake Nona, FL, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC, Canada","institution_ids":["https://openalex.org/I70931966"]},{"raw_affiliation_string":"Precision Pharmacotherapy Research and Development Institute, Tabula Rasa HealthCare, Lake Nona, FL, United States","institution_ids":["https://openalex.org/I4405271950"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5027219295"],"corresponding_institution_ids":["https://openalex.org/I4405271950"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":2.4189,"has_fulltext":true,"cited_by_count":70,"citation_normalized_percentile":{"value":0.92102226,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"8","issue":null,"first_page":"789931","last_page":"789931"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ldl-cholesterol-lowering","display_name":"LDL cholesterol lowering","score":0.871999979019165},{"id":"https://openalex.org/keywords/non-statin-therapy","display_name":"non-statin therapy","score":0.8820000290870667},{"id":"https://openalex.org/keywords/ezetimibe","display_name":"ezetimibe","score":0.9660000205039978},{"id":"https://openalex.org/keywords/pcsk9-inhibitors","display_name":"PCSK9 inhibitors","score":1.0},{"id":"https://openalex.org/keywords/bempedoic-acid","display_name":"bempedoic acid","score":0.9990000128746033},{"id":"https://openalex.org/keywords/inclisiran","display_name":"inclisiran","score":1.0},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.9769999980926514},{"id":"https://openalex.org/keywords/atherosclerotic-cardiovascular-disease","display_name":"atherosclerotic cardiovascular disease","score":0.9850000143051147},{"id":"https://openalex.org/keywords/statin-intolerance","display_name":"statin intolerance","score":0.8619999885559082},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8410000205039978},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7509999871253967},{"id":"https://openalex.org/keywords/cardiovascular-outcomes","display_name":"cardiovascular outcomes","score":0.33500000834465027}],"concepts":[{"id":"https://openalex.org/C2778657065","wikidata":"https://www.wikidata.org/wiki/Q417997","display_name":"Ezetimibe","level":3,"score":0.9815323352813721},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8233819007873535},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.6947736740112305},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5753207802772522},{"id":"https://openalex.org/C2780948078","wikidata":"https://www.wikidata.org/wiki/Q21130010","display_name":"PCSK9","level":5,"score":0.5705068111419678},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.5581931471824646},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5238109827041626},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.49413326382637024},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4581415355205536},{"id":"https://openalex.org/C152163801","wikidata":"https://www.wikidata.org/wiki/Q2146057","display_name":"Residual risk","level":2,"score":0.43487444519996643},{"id":"https://openalex.org/C2909478654","wikidata":"https://www.wikidata.org/wiki/Q844935","display_name":"Atherosclerotic cardiovascular disease","level":3,"score":0.43386340141296387},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4210342466831207},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3813557028770447},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.32870304584503174},{"id":"https://openalex.org/C43554185","wikidata":"https://www.wikidata.org/wiki/Q425649","display_name":"LDL receptor","level":4,"score":0.14250484108924866}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fcvm.2021.789931","doi":"https://doi.org/10.3389/fcvm.2021.789931","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fcvm.2021.789931","pdf_url":"https://www.frontiersin.org/articles/10.3389/fcvm.2021.789931/pdf","source":{"id":"https://openalex.org/S2595413687","display_name":"Frontiers in Cardiovascular Medicine","issn_l":"2297-055X","issn":["2297-055X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","oarl","poland-40","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Cardiovascular Medicine","raw_type":"journal-article"},{"id":"pmid:34869702","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34869702","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in cardiovascular medicine","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8635697","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8635697/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Cardiovasc Med","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:66534c214f3c452c9cb96c64a988deac","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/66534c214f3c452c9cb96c64a988deac","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Cardiovascular Medicine, Vol 8 (2021)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fcvm.2021.789931","doi":"https://doi.org/10.3389/fcvm.2021.789931","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fcvm.2021.789931","pdf_url":"https://www.frontiersin.org/articles/10.3389/fcvm.2021.789931/pdf","source":{"id":"https://openalex.org/S2595413687","display_name":"Frontiers in Cardiovascular Medicine","issn_l":"2297-055X","issn":["2297-055X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","oarl","poland-40","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Cardiovascular Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3213036992.pdf","grobid_xml":"https://content.openalex.org/works/W3213036992.grobid-xml"},"referenced_works_count":83,"referenced_works":["https://openalex.org/W121888607","https://openalex.org/W161816689","https://openalex.org/W1423581981","https://openalex.org/W1520609538","https://openalex.org/W1890541571","https://openalex.org/W1983422922","https://openalex.org/W1987507883","https://openalex.org/W1989730880","https://openalex.org/W1992084132","https://openalex.org/W1995116750","https://openalex.org/W2001328643","https://openalex.org/W2004936310","https://openalex.org/W2005716172","https://openalex.org/W2015503831","https://openalex.org/W2019071303","https://openalex.org/W2021879218","https://openalex.org/W2063604501","https://openalex.org/W2093260782","https://openalex.org/W2101702589","https://openalex.org/W2106285889","https://openalex.org/W2111385165","https://openalex.org/W2119708151","https://openalex.org/W2134120087","https://openalex.org/W2155259933","https://openalex.org/W2163252871","https://openalex.org/W2167045683","https://openalex.org/W2181911369","https://openalex.org/W2291773302","https://openalex.org/W2319057797","https://openalex.org/W2412920036","https://openalex.org/W2417076517","https://openalex.org/W2469346154","https://openalex.org/W2475261460","https://openalex.org/W2486690983","https://openalex.org/W2511420668","https://openalex.org/W2511907480","https://openalex.org/W2521647868","https://openalex.org/W2555483953","https://openalex.org/W2558991743","https://openalex.org/W2589921037","https://openalex.org/W2595169180","https://openalex.org/W2596179513","https://openalex.org/W2738949577","https://openalex.org/W2740472173","https://openalex.org/W2746224452","https://openalex.org/W2757304856","https://openalex.org/W2765432372","https://openalex.org/W2768588165","https://openalex.org/W2780743843","https://openalex.org/W2785715927","https://openalex.org/W2808641584","https://openalex.org/W2842001711","https://openalex.org/W2885991601","https://openalex.org/W2892430049","https://openalex.org/W2899997727","https://openalex.org/W2900034165","https://openalex.org/W2900103074","https://openalex.org/W2906853807","https://openalex.org/W2909765747","https://openalex.org/W2912189308","https://openalex.org/W2922038538","https://openalex.org/W2928534885","https://openalex.org/W2946347198","https://openalex.org/W2949589992","https://openalex.org/W2955932804","https://openalex.org/W2961122604","https://openalex.org/W2965327853","https://openalex.org/W2969581025","https://openalex.org/W2970332864","https://openalex.org/W2970862045","https://openalex.org/W2980761229","https://openalex.org/W2987162559","https://openalex.org/W2987850771","https://openalex.org/W3012265841","https://openalex.org/W3014622477","https://openalex.org/W3030015132","https://openalex.org/W3042368998","https://openalex.org/W3048679999","https://openalex.org/W3080449802","https://openalex.org/W3129818723","https://openalex.org/W3138949428","https://openalex.org/W3176670679","https://openalex.org/W4293170937"],"related_works":["https://openalex.org/W4414984365","https://openalex.org/W2976529470","https://openalex.org/W2971757960","https://openalex.org/W2772235814","https://openalex.org/W2790280068","https://openalex.org/W4400000010","https://openalex.org/W4392371572","https://openalex.org/W4288766480","https://openalex.org/W3165316972","https://openalex.org/W3016672286"],"abstract_inverted_index":{"Low-density":[0],"lipoprotein":[1],"cholesterol":[2,24,42,61],"(LDL-C)":[3],"is":[4],"a":[5],"modifiable":[6],"risk":[7],"factor":[8],"for":[9,22,127],"the":[10,19,28,96],"development":[11],"of":[12,59,100],"atherosclerotic":[13,32],"cardiovascular":[14,33,70,123],"disease.":[15],"Statins":[16],"have":[17,68,80],"been":[18],"gold":[20],"standard":[21],"managing":[23],"levels":[25],"and":[26,72,86,105,107,115,119,122],"reducing":[27],"risks":[29],"associated":[30],"with":[31],"disease;":[34],"however,":[35],"many":[36],"patients":[37],"do":[38],"not":[39],"achieve":[40],"their":[41,109],"goals":[43],"or":[44],"are":[45],"unable":[46],"to":[47,53,94],"tolerate":[48],"this":[49],"drug":[50,55],"class":[51],"due":[52],"adverse":[54],"events.":[56],"Recent":[57],"studies":[58],"non-statin":[60],"lowering":[62],"drugs":[63,74],"(i.e.,":[64],"ezetimibe,":[65,101],"PCSK9":[66,102],"inhibitors)":[67],"demonstrated":[69],"benefits;":[71],"new":[73],"[i.e.,":[75],"bempedoic":[76],"acid":[77],"(BDA),":[78],"inclisiran]":[79],"produced":[81],"promising":[82],"results":[83],"in":[84,98],"pre-clinical":[85],"clinical":[87],"outcome":[88],"trials.":[89],"This":[90],"narrative":[91],"review":[92],"aims":[93],"discuss":[95],"place":[97],"therapy":[99],"inhibitors,":[103],"BDA,":[104],"inclisiran":[106],"describe":[108],"relative":[110],"pharmacokinetic":[111],"(PK)":[112],"profiles,":[113],"efficacy":[114],"safety":[116],"as":[117],"monotherapy":[118],"combination":[120],"therapy,":[121],"benefit(s)":[124],"when":[125],"used":[126],"hypercholesterolemia.":[128]},"counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":15},{"year":2023,"cited_by_count":20},{"year":2022,"cited_by_count":15}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2021-11-22T00:00:00"}